Intervention

ACC-001

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions2
Lead sponsors shown1

Clinical trials

5 shown
Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseNCT01238991 · 2010-12-01
TERMINATED
Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseNCT00959192 · 2009-08-01
COMPLETED
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's DiseaseNCT00752232 · 2008-12-01
COMPLETED
Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseNCT00498602 · 2007-11-01
COMPLETED
Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseNCT00479557 · 2007-05-01
COMPLETED

Trial status mix

COMPLETED4
TERMINATED1

Phase mix

PHASE25

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.